The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer

William Tapper,Gustavo Carneiro,Christos Mikropoulos,Spencer A. Thomas,Philip M. Evans,Stergios Boussios

DOI: https://doi.org/10.3390/jpm14030287

IF: 3.5083

2024-03-08

Journal of Personalized Medicine

Abstract:Molecular imaging is a key tool in the diagnosis and treatment of prostate cancer (PCa). Magnetic Resonance (MR) plays a major role in this respect with nuclear medicine imaging, particularly, Prostate-Specific Membrane Antigen-based, (PSMA-based) positron emission tomography with computed tomography (PET/CT) also playing a major role of rapidly increasing importance. Another key technology finding growing application across medicine and specifically in molecular imaging is the use of machine learning (ML) and artificial intelligence (AI). Several authoritative reviews are available of the role of MR-based molecular imaging with a sparsity of reviews of the role of PET/CT. This review will focus on the use of AI for molecular imaging for PCa. It will aim to achieve two goals: firstly, to give the reader an introduction to the AI technologies available, and secondly, to provide an overview of AI applied to PET/CT in PCa. The clinical applications include diagnosis, staging, target volume definition for treatment planning, outcome prediction and outcome monitoring. ML and AL techniques discussed include radiomics, convolutional neural networks (CNN), generative adversarial networks (GAN) and training methods: supervised, unsupervised and semi-supervised learning.

medicine, general & internal,health care sciences & services

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to apply radiomics and artificial intelligence (AI) technologies in the molecular imaging of prostate cancer (PCa), in order to improve the accuracy and efficiency of disease diagnosis, staging, treatment planning, prognosis prediction and monitoring. Specifically, the paper focuses on the following aspects:

1. **Introducing AI Technologies**: Introduce available AI technologies to readers, including radiomics, convolutional neural networks (CNN), generative adversarial networks (GAN), and training methods such as supervised learning, unsupervised learning and semi - supervised learning.

2. **Application of AI in PET/CT**: Provide an overview of the application of AI technologies in PET/CT imaging of prostate cancer, including applications in lesion detection, disease staging, treatment planning and prognosis prediction.

3. **Clinical Applications**: Explore in detail how AI technologies play a role in the clinical applications of prostate cancer, such as early detection and staging, prognosis prediction based on complex data patterns.

4. **Technical Details**: Discuss the working principles of different AI technologies and their specific applications in prostate cancer imaging, including radiomics feature extraction, the application of CNN in image classification and segmentation.

Through these studies, the paper aims to demonstrate the potential of AI technologies in the molecular imaging of prostate cancer, support clinicians in making more accurate decisions, and improve the survival rate and quality of life of patients.